AIMS: Little is known about the impact of ICD indication (primary vs. secondary) on health-related quality of life (HRQL). Indication may also interact with psychological factors, such as personality. Using a prospective design, we examined whether ICD indication and type-D personality (i.e. experiencing increased negative emotions paired with emotional non-expression) serve as modulators of HRQL at baseline and 3 months post-implantation. METHODS AND RESULTS: Consecutively implanted ICD patients (n = 154) completed the Type-D Scale (DS14) at baseline and the Short-Form Health Survey 36 (SF-36) at baseline and 3 months. Of all patients, 82 (53%) received an ICD due to prophylactic reasons; the prevalence of type-D was 23%. Indication had no influence on HRQL (P = 0.75). Further stratification by personality showed a main effect for type-D personality (P < 0.001), with type-D patients generally experiencing poorer HRQL; there was no main effect for indication (P = 0.45) nor was the interaction effect indication by type-D significant (P = 0.22). There was a significant improvement in HRQL over time (P = 0.001). Type-D remained an independent predictor of impaired HRQL, adjusting for clinical factors and shocks during follow-up (P < 0.001). However, in adjusted analysis there was no longer a significant change in HRQL over time (P = 0.099). CONCLUSION: Type-D personality but not ICD indication was associated with impaired HRQL at the time of implantation and at 3 months. In the quest for enhancing risk stratification in clinical practice, personality factors, such as type-D, should not be ignored, as both type-D and poor HRQL have been associated with increased risk of mortality in cardiac patients.
AIMS: Little is known about the impact of ICD indication (primary vs. secondary) on health-related quality of life (HRQL). Indication may also interact with psychological factors, such as personality. Using a prospective design, we examined whether ICD indication and type-D personality (i.e. experiencing increased negative emotions paired with emotional non-expression) serve as modulators of HRQL at baseline and 3 months post-implantation. METHODS AND RESULTS: Consecutively implanted ICDpatients (n = 154) completed the Type-D Scale (DS14) at baseline and the Short-Form Health Survey 36 (SF-36) at baseline and 3 months. Of all patients, 82 (53%) received an ICD due to prophylactic reasons; the prevalence of type-D was 23%. Indication had no influence on HRQL (P = 0.75). Further stratification by personality showed a main effect for type-D personality (P < 0.001), with type-D patients generally experiencing poorer HRQL; there was no main effect for indication (P = 0.45) nor was the interaction effect indication by type-D significant (P = 0.22). There was a significant improvement in HRQL over time (P = 0.001). Type-D remained an independent predictor of impaired HRQL, adjusting for clinical factors and shocks during follow-up (P < 0.001). However, in adjusted analysis there was no longer a significant change in HRQL over time (P = 0.099). CONCLUSION: Type-D personality but not ICD indication was associated with impaired HRQL at the time of implantation and at 3 months. In the quest for enhancing risk stratification in clinical practice, personality factors, such as type-D, should not be ignored, as both type-D and poor HRQL have been associated with increased risk of mortality in cardiac patients.
Authors: Krista C van den Broek; Nina Kupper; Pepijn H van der Voort; Marco Alings; Johan Denollet; Ivan Nyklíček Journal: Int J Behav Med Date: 2014-02
Authors: Annemieke H Starrenburg; Karin Kraaier; Susanne S Pedersen; Moniek van Hout; Marcoen Scholten; Job van der Palen Journal: Int J Behav Med Date: 2013-09
Authors: W Anné; D A M J Theuns; B Schaer; Y Van Belle; T Szili-Torok; T Smith; J Res; L Jordaens Journal: Neth Heart J Date: 2014-06 Impact factor: 2.380
Authors: I-Chan Huang; Joy L Lee; Pavinarmatha Ketheeswaran; Conor M Jones; Dennis A Revicki; Albert W Wu Journal: PLoS One Date: 2017-03-29 Impact factor: 3.240
Authors: M Habibović; L Mudde; S S Pedersen; D Schoormans; J Widdershoven; J Denollet Journal: Eur J Cardiovasc Nurs Date: 2017-12-20 Impact factor: 3.908
Authors: Kevin Willy; Christian Ellermann; Florian Reinke; Benjamin Rath; Julian Wolfes; Lars Eckardt; Florian Doldi; Felix K Wegner; Julia Köbe; Nexhmedin Morina Journal: J Cardiovasc Dev Dis Date: 2022-08-10
Authors: Susanne S Pedersen; Viola Spek; Dominic A M J Theuns; Marco Alings; Pepijn van der Voort; Luc Jordaens; Pim Cuijpers; Johan Denollet; Krista C van den Broek Journal: Trials Date: 2009-12-23 Impact factor: 2.279
Authors: Sandra L Carroll; Michael McGillion; Dawn Stacey; Jeff S Healey; Gina Browne; Heather M Arthur; Lehana Thabane Journal: Trials Date: 2013-10-22 Impact factor: 2.279